Dr. Ken H.Young is currently working as a Professor in the Department of Hematopathology at The University of Texas MD Anderson Cancer Center, USA. Dr. Young has completed his MD in 1984 from Zhejiang University School of Medicine, China. Later, he has received his Ph.D. from University of Lund School of Medicine, Sweden in 1995. Dr. Young’s team is focusing on several types of hematologic malignancies, with special emphasis on pathogenesis of malignant lymphomas, especially diffuse large B-cell lymphoma (DLBCL). The goal of his team is to explore and identify genetic and non-genetic biomarkers, including p53, Myc, pTEN, Mdm2, Arf, Bcl-2, Bcl-6 genes, alone or in combination with other abnormalities in DLBCL, that predict cancer prognosis and susceptibility.
Dr. Young’s primary study of genomic alterations is on TP53 tumor suppressor pathway and secondary focus is on Myc oncogene.
Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.